Citigroup’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $333K | Sell |
40,854
-29,071
| -42% | -$264K | ﹤0.01% | 3757 |
|
|
2025
Q4 | $470K | Buy |
69,925
+43,511
| +165% | +$328K | ﹤0.01% | 3606 |
|
|
2025
Q3 | $229K | Sell |
26,414
-96,050
| -78% | -$748K | ﹤0.01% | 3936 |
|
|
2025
Q2 | $772K | Sell |
122,464
-224,866
| -65% | -$1.49M | ﹤0.01% | 3341 |
|
|
2025
Q1 | $2.23M | Sell |
347,330
-694,776
| -67% | -$5.74M | ﹤0.01% | 2602 |
|
|
2024
Q4 | $8.38M | Sell |
1,042,106
-93,116
| -8% | -$898K | 0.01% | 1514 |
|
|
2024
Q3 | $14.3M | Buy |
1,135,222
+275,352
| +32% | +$3.56M | 0.01% | 1137 |
|
|
2024
Q2 | $10.9M | Sell |
859,870
-895,940
| -51% | -$9.01M | 0.01% | 1201 |
|
|
2024
Q1 | $8.39M | Buy |
1,755,810
+562,053
| +47% | +$2.61M | 0.01% | 1347 |
|
|
2023
Q4 | $5.73M | Sell |
1,193,757
-371,196
| -24% | -$2.27M | ﹤0.01% | 1499 |
|
|
2023
Q3 | $11.3M | Buy |
1,564,953
+1,101,180
| +237% | +$8.8M | 0.01% | 1044 |
|
|
2023
Q2 | $3.45M | Sell |
463,773
-1,239,048
| -73% | -$9.74M | ﹤0.01% | 1754 |
|
|
2023
Q1 | $11.8M | Buy |
1,702,821
+139,696
| +9% | +$1.29M | 0.01% | 1083 |
|
|
2022
Q4 | $16.1M | Buy |
1,563,125
+134,767
| +9% | +$2.38M | 0.01% | 893 |
|
|
2022
Q3 | $26M | Buy |
1,428,358
+205,555
| +17% | +$8.91M | 0.02% | 654 |
|
|
2022
Q2 | $62.9M | Buy |
1,222,803
+812,996
| +198% | +$42.1M | 0.05% | 322 |
|
|
2022
Q1 | $30.2M | Buy |
409,807
+221,317
| +117% | +$19.7M | 0.02% | 725 |
|
|
2021
Q4 | $27M | Buy |
188,490
+70,276
| +59% | +$12.1M | 0.01% | 857 |
|
|
2021
Q3 | $24.5M | Sell |
118,214
-12,637
| -10% | -$2.79M | 0.01% | 880 |
|
|
2021
Q2 | $27.8M | Buy |
130,851
+27,909
| +27% | +$5.11M | 0.02% | 814 |
|
|
2021
Q1 | $18.7M | Buy |
102,942
+81,900
| +389% | +$16.3M | 0.01% | 993 |
|
|
2020
Q4 | $2.35M | Buy |
21,042
+14,121
| +204% | +$1.5M | ﹤0.01% | 2707 |
|
|
2020
Q3 | $750K | Sell |
6,921
-647,499
| -99% | -$78.9M | ﹤0.01% | 3525 |
|
|
2020
Q2 | $54.5M | Buy |
654,420
+642,369
| +5,330% | +$24.6M | 0.04% | 373 |
|
|
2020
Q1 | $164K | Buy |
12,051
+5,533
| +85% | +$46.8K | ﹤0.01% | 4904 |
|
|
2019
Q4 | $26K | Sell |
6,518
-3,493
| -35% | -$15.2K | ﹤0.01% | 6800 |
|
|
2019
Q3 | $50K | Buy |
10,011
+3
| +0% | +$16 | ﹤0.01% | 6132 |
|
|
2019
Q2 | $59K | Buy |
10,008
+727
| +8% | +$5.72K | ﹤0.01% | 6321 |
|
|
2019
Q1 | $102K | Sell |
9,281
-76,544
| -89% | -$2.42M | ﹤0.01% | 5729 |
|
|
2018
Q4 | $3.16M | Buy |
85,825
+36,198
| +73% | +$1.4M | ﹤0.01% | 2259 |
|
|
2018
Q3 | $1.87M | Buy |
49,627
+12,961
| +35% | +$365K | ﹤0.01% | 2812 |
|
|
2018
Q2 | $982K | Sell |
36,666
-9,634
| -21% | -$326K | ﹤0.01% | 3381 |
|
|
2018
Q1 | $1.95M | Buy |
46,300
+17,558
| +61% | +$705K | ﹤0.01% | 2621 |
|
|
2017
Q4 | $713K | Buy |
28,742
+22,531
| +363% | +$550K | ﹤0.01% | 3701 |
|
|
2017
Q3 | $142K | Buy |
6,211
+896
| +17% | +$20.1K | ﹤0.01% | 5274 |
|
|
2017
Q2 | $123K | Sell |
5,315
-1,266
| -19% | -$24.8K | ﹤0.01% | 5183 |
|
|
2017
Q1 | $169K | Sell |
6,581
-59,046
| -90% | -$1.62M | ﹤0.01% | 4800 |
|
|
2016
Q4 | $1.65M | Buy |
65,627
+52,278
| +392% | +$1.52M | ﹤0.01% | 3154 |
|
|
2016
Q3 | $555K | Buy |
13,349
+7,050
| +112% | +$910K | ﹤0.01% | 3806 |
|
|
2016
Q2 | $916K | Sell |
6,299
-29,253
| -82% | -$3.35M | ﹤0.01% | 3054 |
|
|
2016
Q1 | $3.67M | Buy |
35,552
+32,780
| +1,183% | +$3.52M | ﹤0.01% | 1843 |
|
|
2015
Q4 | $465K | Sell |
2,772
-1,386
| -33% | -$213K | ﹤0.01% | 3934 |
|
|
2015
Q3 | $588K | Buy |
4,158
+1,051
| +34% | +$236K | ﹤0.01% | 3592 |
|
|
2015
Q2 | $691K | Sell |
3,107
-321
| -9% | -$56.4K | ﹤0.01% | 3417 |
|
|
2015
Q1 | $568K | Sell |
3,428
-2,980
| -47% | -$484K | ﹤0.01% | 3616 |
|
|
2014
Q4 | $761K | Buy |
6,408
+620
| +11% | +$64.8K | ﹤0.01% | 3427 |
|
|
2014
Q3 | $483K | Buy |
5,788
+4,604
| +389% | +$416K | ﹤0.01% | 3559 |
|
|
2014
Q2 | $109K | Sell |
1,184
-1,410
| -54% | -$124K | ﹤0.01% | 4604 |
|
|
2014
Q1 | $234K | Sell |
2,594
-2,489
| -49% | -$278K | ﹤0.01% | 4183 |
|
|
2013
Q4 | $521K | Buy |
5,083
+2,084
| +69% | +$147K | ﹤0.01% | 3762 |
|
|
2013
Q3 | $190K | Buy |
2,999
+1,877
| +167% | +$106K | ﹤0.01% | 4202 |
|
|
2013
Q2 | $46K | Buy |
+1,122
| New | +$48.6K | ﹤0.01% | 5420 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Citigroup's NVAX Position: Q1 2026 in Review
Citigroup reduced its Novavax (NVAX) stake by 42% in Q1 2026, selling an estimated $264K and leaving 40,854 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.
Citigroup first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.9M in Q2 2022. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Citigroup held 40,854 shares of Novavax worth $333K as of Q1 2026.
- Citigroup sold 29,071 Novavax shares in Q1 2026, an estimated $264K.
- Novavax made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3757 holding.
- Citigroup first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Novavax position peaked at $62.9M in Q2 2022.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.